New Drug Screening Identifies Chemical Agents With Potent Anti-Cancer Activity, National Cancer Institute Study

Drugs already approved for clinical use across a variety of therapeutic categories can be screened to identify effective agents for thyroid cancer, according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM). These findings could rapidly be implemented into a clinical trial to test how effective the treatment would be.

MORE ON THIS TOPIC